Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
9 Results for "
Vorsetuzumab
" in MedChemExpress (MCE) Product Catalog:
Products (9)
9 Results for "Vorsetuzumab" in MCE Product Catalog:
Cat. No.: HY-P99273
CAS No.: 1165740-62-4
Target:
Research Areas:
9
9 Publications Verification
Synonyms: Monomethylauristatin F
Target:
Research Areas:
MMAF (Monomethylauristatin F) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF (Monomethylauristatin F) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as vorsetuzumab mafodotin and SGN-CD19A .
9
9 Publications Verification
Synonyms: Monomethylauristatin F hydrochloride
Target:
Research Areas:
MMAF (Monomethylauristatin F) hydrochloride is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF hydrochloride is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A .
9
9 Publications Verification
Synonyms: Monomethylauristatin F sodium
Target:
Research Areas:
MMAF sodium (Monomethylauristatin F sodium) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF sodium (Monomethylauristatin F sodium) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A .
Cat. No.: HY-P99334
CAS No.: 1165741-01-4
Synonyms: Anti-Human CD70 Recombinant Antibody; SGN-75
Research Areas:
Vorsetuzumab mafodotin (SGN-75) is an Auristatin-based anti-CD70 antibody-drug conjugate (ADC). Vorsetuzumab mafodotin consists of a humanized monoclonal antibody, Vorsetuzumab and an ADC cytotoxin MMAF. Vorsetuzumab mafodotin has antineoplastic activity .
Cat. No.: HY-15579G
CAS No.: 745017-94-1
Synonyms: Monomethylauristatin F (GMP)
Cat. No.: HY-79254
CAS No.: 864238-20-0
Target:
Research Areas:
MMAF intermediate 2 is an intermediate for the synthesis of MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent inhibitor of tubulin polymerization and the cytotoxic (ADC Cytotoxin) component of classic antibody drug conjugates (ADCs), such as Vorsetuzumab mafodotin and SGN-CD19A .
Cat. No.: HY-79253
CAS No.: 161485-82-1
Target:
Research Areas:
MMAF intermediate 1 is an intermediate in the synthesis of MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent inhibitor of tubulin polymerization and the cytotoxic (ADC Cytotoxin) component of classic antibody drug conjugates (ADCs), such as Vorsetuzumab mafodotin and SGN-CD19A .
Cat. No.: HY-15579BG
CAS No.: 1799706-65-2
Synonyms: Monomethylauristatin F sodium (GMP)
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
